XALI GOLD CORP (XGC.CA) Fundamental Analysis & Valuation

TSX-V:XGC • CA98387F1036

Current stock price

0.28 CAD
-0.01 (-3.45%)
Last:

This XGC.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. XGC.CA Profitability Analysis

1.1 Basic Checks

  • XGC had positive earnings in the past year.
  • In the past year XGC has reported a negative cash flow from operations.
  • In the past 5 years XGC reported 4 times negative net income.
  • In the past 5 years XGC always reported negative operating cash flow.
XGC.CA Yearly Net Income VS EBIT VS OCF VS FCFXGC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2M -4M -6M -8M

1.2 Ratios

  • XGC has a better Return On Assets (4.92%) than 89.01% of its industry peers.
Industry RankSector Rank
ROA 4.92%
ROE N/A
ROIC N/A
ROA(3y)702.23%
ROA(5y)304.99%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XGC.CA Yearly ROA, ROE, ROICXGC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K -1K 2K -2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for XGC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XGC.CA Yearly Profit, Operating, Gross MarginsXGC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

0

2. XGC.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for XGC has been increased compared to 1 year ago.
  • XGC has more shares outstanding than it did 5 years ago.
  • XGC has a worse debt/assets ratio than last year.
XGC.CA Yearly Shares OutstandingXGC.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
XGC.CA Yearly Total Debt VS Total AssetsXGC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

  • XGC has an Altman-Z score of -2.94. This is a bad value and indicates that XGC is not financially healthy and even has some risk of bankruptcy.
  • XGC's Altman-Z score of -2.94 is on the low side compared to the rest of the industry. XGC is outperformed by 67.54% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.94
ROIC/WACCN/A
WACCN/A
XGC.CA Yearly LT Debt VS Equity VS FCFXGC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M 6M

2.3 Liquidity

  • A Current Ratio of 0.32 indicates that XGC may have some problems paying its short term obligations.
  • The Current ratio of XGC (0.32) is worse than 75.78% of its industry peers.
  • XGC has a Quick Ratio of 0.32. This is a bad value and indicates that XGC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • XGC has a worse Quick ratio (0.32) than 75.16% of its industry peers.
Industry RankSector Rank
Current Ratio 0.32
Quick Ratio 0.32
XGC.CA Yearly Current Assets VS Current LiabilitesXGC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M

1

3. XGC.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 266.67% over the past year.
EPS 1Y (TTM)266.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-171.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. XGC.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 28.00, XGC can be considered very expensive at the moment.
  • 89.64% of the companies in the same industry are more expensive than XGC, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.89. XGC is around the same levels.
Industry RankSector Rank
PE 28
Fwd PE N/A
XGC.CA Price Earnings VS Forward Price EarningsXGC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XGC.CA Per share dataXGC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.01 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. XGC.CA Dividend Analysis

5.1 Amount

  • XGC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

XGC.CA Fundamentals: All Metrics, Ratios and Statistics

XALI GOLD CORP

TSX-V:XGC (4/17/2026, 7:00:00 PM)

0.28

-0.01 (-3.45%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-02
Earnings (Next)N/A
Inst Owners3.82%
Inst Owner ChangeN/A
Ins Owners9.35%
Ins Owner ChangeN/A
Market Cap45.13M
Revenue(TTM)N/A
Net Income(TTM)555.70K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 28
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.01
EY3.57%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 4.92%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)702.23%
ROA(5y)304.99%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.32
Quick Ratio 0.32
Altman-Z -2.94
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)266.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-171.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10537.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4425.53%
OCF growth 3YN/A
OCF growth 5YN/A

XALI GOLD CORP / XGC.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of XALI GOLD CORP (XGC.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to XGC.CA.


What is the valuation status for XGC stock?

ChartMill assigns a valuation rating of 1 / 10 to XALI GOLD CORP (XGC.CA). This can be considered as Overvalued.


Can you provide the profitability details for XALI GOLD CORP?

XALI GOLD CORP (XGC.CA) has a profitability rating of 1 / 10.